Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study
Condition(s):Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)Last Updated:March 13, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)Last Updated:March 13, 2024Recruiting
Condition(s):Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)Last Updated:February 15, 2024Active, not recruiting
Condition(s):CLLLast Updated:November 15, 2023Recruiting
Condition(s):COVID-19Last Updated:November 17, 2021Terminated
Condition(s):Mantle Cell Lymphoma (MCL)Last Updated:March 6, 2024Recruiting
Condition(s):Chronic Lymphocytic Leukemia; Small Lymphocytic LymphomaLast Updated:March 22, 2024Recruiting
Condition(s):BioequivalenceLast Updated:July 8, 2022Completed
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:January 16, 2024Recruiting
Condition(s):Chronic Lymphocytic Leukemia, CLLLast Updated:February 15, 2024Recruiting
Condition(s):Food Allergy; Food Allergy PeanutLast Updated:September 28, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.